Trending Now
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announces a Research and Option Agreement...
When Covid-19 hit the globe earlier in the year, no one, not even the scientific researchers and experts, knew much about it. Today, we...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Mangoceuticals Inc (MGRX) Leverages Podcast Popularity to Promote Men’s Wellness Product
Dallas, Texas, July 27, 2023 - In a major stride towards improving its market presence, Mangoceuticals Inc. (NASDAQ: MGRX), a leading brand...
MAKE IT MODERN
LATEST REVIEWS
Sustainable Energy Stocks 2.0 Emerging Opportunities in the Wake of COP26...
The Environment, Social, and Governance investment theme – also known as ESG investing – is anticipated to power as much as $67...
MAKE IT MODERN
PERFORMANCE TRAINING
Clovis Oncology Inc. (NASDAQ:CLVS) Announces NCCN’s Updated Guidelines To Include Rubraca Tablets As A...
Clovis Oncology Inc. (NASDAQ:CLVS) has announced that Rubraca (rucaparib) tablets have been approved for the treatment of BRCA-mutant mCRPC in a second-line setting as...
Synthetic Biologics Inc (NYSE: SYN) adds an Exclusive License Option with Massachusetts General Hospital
Synthetic Biologics Inc (NYSE: SYN) is a diversified preclinical stage corporation that leverages microbiome functionality to develop medical therapies designed to treat and prevent GI...
The European Patent Office Notifies Can-Fite Biopha (NYSEAMERICAN:CANF) Of Its Patent Grant For Namodenoson...
Throughout its many years of operation, Can-Fite Biopha (NYSEAMERICAN:CANF) has been addressing multi-billion dollar markets. Its primary target has been the advancement of cancer...
Is Loyalty Ventures Inc (LYLT) more than a dead cat bounce
Shares of Loyalty Ventures Inc. (NASDAQ:LYLT) last traded at $0.2709, a gain of over +0.1009$ (+59.35%). More than 194,654,676 shares exchanged hands...
Preclinical studies of a COVID-19 vaccine by Altimmune Inc (NASDAQ:ALT) at UAB Shows Potent...
There are hundreds of preclinical studies of a COVID-19 vaccine currently under development. Those in the advanced stages include AdCOVID from Altimmune Inc (NASDAQ:ALT)....
MAKE IT MODERN
